APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

9-valent HPV Vaccine (9vHPV)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global 9-valent HPV Vaccine (9vHPV) Industry Growth and Trends Forecast to 2032

19 December 202563 pages

Choose your research edition.

Industry Research9-valent HPV Vaccine (9vHPV) Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal 9-valent HPV Vaccine (9vHPV) Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal 9-valent HPV Vaccine (9vHPV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 9-valent HPV Vaccine (9vHPV) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal 9-valent HPV Vaccine (9vHPV) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global 9-valent HPV Vaccine (9vHPV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the 9-valent HPV Vaccine (9vHPV) market include GSK, Merck and Beijing Wantai Biology Pharmaceutical Industry Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 9-valent HPV Vaccine (9vHPV) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 9-valent HPV Vaccine (9vHPV) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 9-valent HPV Vaccine (9vHPV) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 9-valent HPV Vaccine (9vHPV).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global 9-valent HPV Vaccine (9vHPV) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

9-valent HPV Vaccine (9vHPV) Market by Company

GSK

Merck

Beijing Wantai Biology Pharmaceutical Industry Limited

9-valent HPV Vaccine (9vHPV) Segment by Type

9—14

15—19

20—45

9-valent HPV Vaccine (9vHPV) Segment by Application

Men

Women

9-valent HPV Vaccine (9vHPV) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 9-valent HPV Vaccine (9vHPV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 9-valent HPV Vaccine (9vHPV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 9-valent HPV Vaccine (9vHPV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of 9-valent HPV Vaccine (9vHPV) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global 9-valent HPV Vaccine (9vHPV) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region (2021-2026) Table 4. Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region (2027-2032) Table 6. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2026) Table 9. Global 9-valent HPV Vaccine (9vHPV) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global 9-valent HPV Vaccine (9vHPV) Market Size Share Forecasted by Type (2027-2032) Table 11. North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2026) Table 24. Global 9-valent HPV Vaccine (9vHPV) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global 9-valent HPV Vaccine (9vHPV) Market Size Share Forecasted by Application (2027-2032) Table 26. North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. 9-valent HPV Vaccine (9vHPV) Industry Trends Table 37. 9-valent HPV Vaccine (9vHPV) Industry Drivers Table 38. 9-valent HPV Vaccine (9vHPV) Industry Opportunities and Challenges Table 39. 9-valent HPV Vaccine (9vHPV) Industry Restraints Table 40. Global 9-valent HPV Vaccine (9vHPV) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Company (2021-2026) Table 42. Global 9-valent HPV Vaccine (9vHPV) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global 9-valent HPV Vaccine (9vHPV) Key Company Headquarters & Area Served Table 44. Global 9-valent HPV Vaccine (9vHPV) Company, Product Type & Application Table 45. Global 9-valent HPV Vaccine (9vHPV) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global 9-valent HPV Vaccine (9vHPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK 9-valent HPV Vaccine (9vHPV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GSK 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 52. GSK Recent Development Table 53. Merck Company Information Table 54. Merck Business Overview Table 55. Merck 9-valent HPV Vaccine (9vHPV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 57. Merck Recent Development Table 58. Beijing Wantai Biology Pharmaceutical Industry Limited Company Information Table 59. Beijing Wantai Biology Pharmaceutical Industry Limited Business Overview Table 60. Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 62. Beijing Wantai Biology Pharmaceutical Industry Limited Recent Development Table 63. North America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 64. North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) & (US$ Million) Table 65. North America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2026) Table 66. North America 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 67. North America 9-valent HPV Vaccine (9vHPV) Market Share Forecast by Country (2027-2032) Table 68. Europe 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 69. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) & (US$ Million) Table 70. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2026) Table 71. Europe 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 72. Europe 9-valent HPV Vaccine (9vHPV) Market Share Forecast by Country (2027-2032) Table 73. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) & (US$ Million) Table 75. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2026) Table 76. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Share Forecast by Country (2027-2032) Table 78. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Latin America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) & (US$ Million) Table 80. Latin America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2026) Table 81. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Latin America 9-valent HPV Vaccine (9vHPV) Market Share Forecast by Country (2027-2032) Table 83. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) & (US$ Million) Table 85. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2026) Table 86. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share Forecast by Country (2027-2032) Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. 9-valent HPV Vaccine (9vHPV) Product Image Figure 3. Global 9-valent HPV Vaccine (9vHPV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 5. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region: 2025 VS 2032 Figure 6. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region (2021-2032) Figure 7. North America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 9—14 Image Figure 13. Global 9—14 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 15—19 Image Figure 15. Global 15—19 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 20—45 Image Figure 17. Global 20—45 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global 9-valent HPV Vaccine (9vHPV) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global 9-valent HPV Vaccine (9vHPV) Market Share by Type 2025 VS 2032 Figure 20. North America 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032) Figure 21. Europe 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032) Figure 23. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032) Figure 25. Men Image Figure 26. Global Men Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Women Image Figure 28. Global Women Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global 9-valent HPV Vaccine (9vHPV) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global 9-valent HPV Vaccine (9vHPV) Market Share by Application 2025 VS 2032 Figure 31. North America 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032) Figure 32. Europe 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032) Figure 34. Latin America 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 9-valent HPV Vaccine (9vHPV) Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America 9-valent HPV Vaccine (9vHPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America 9-valent HPV Vaccine (9vHPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 41. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 44. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 47. Latin America 9-valent HPV Vaccine (9vHPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America 9-valent HPV Vaccine (9vHPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 50. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • 9—14
  • 15—19
  • 20—45
Applications
  • Men
  • Women
Companies covered
  • GSK
  • Merck
  • Beijing Wantai Biology Pharmaceutical Industry Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global 9-valent HPV Vaccine (9vHPV) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2021-2032)
  5. 1.4.1 Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2021-2026)
  6. 1.4.2 Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2027-2032)
  7. 1.5 Key Regions 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  8. 1.5.1 North America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (2021-2032)
2 9-valent HPV Vaccine (9vHPV) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 9—14
  3. 2.1.2 15—19
  4. 2.1.3 20—45
  5. 2.2 Global 9-valent HPV Vaccine (9vHPV) Market Size by Type
  6. 2.2.1 Global 9-valent HPV Vaccine (9vHPV) Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global 9-valent HPV Vaccine (9vHPV) Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global 9-valent HPV Vaccine (9vHPV) Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global 9-valent HPV Vaccine (9vHPV) Market Size by Regions
  10. 2.3.1 North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Type (2021-2026)
3 9-valent HPV Vaccine (9vHPV) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Men
  3. 3.1.2 Women
  4. 3.2 Global 9-valent HPV Vaccine (9vHPV) Market Size by Application
  5. 3.2.1 Global 9-valent HPV Vaccine (9vHPV) Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global 9-valent HPV Vaccine (9vHPV) Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global 9-valent HPV Vaccine (9vHPV) Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global 9-valent HPV Vaccine (9vHPV) Market Size by Regions
  9. 3.3.1 North America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa 9-valent HPV Vaccine (9vHPV) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 9-valent HPV Vaccine (9vHPV) Industry Trends
  2. 4.2 9-valent HPV Vaccine (9vHPV) Industry Drivers
  3. 4.3 9-valent HPV Vaccine (9vHPV) Industry Opportunities and Challenges
  4. 4.4 9-valent HPV Vaccine (9vHPV) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by 9-valent HPV Vaccine (9vHPV) Revenue (2021-2026)
  2. 5.2 Global 9-valent HPV Vaccine (9vHPV) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global 9-valent HPV Vaccine (9vHPV) Key Company Headquarters & Area Served
  4. 5.4 Global 9-valent HPV Vaccine (9vHPV) Company, Product Type & Application
  5. 5.5 Global 9-valent HPV Vaccine (9vHPV) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global 9-valent HPV Vaccine (9vHPV) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 9-valent HPV Vaccine (9vHPV) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 9-valent HPV Vaccine (9vHPV) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK 9-valent HPV Vaccine (9vHPV) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GSK 9-valent HPV Vaccine (9vHPV) Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck 9-valent HPV Vaccine (9vHPV) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck 9-valent HPV Vaccine (9vHPV) Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Beijing Wantai Biology Pharmaceutical Industry Limited
  14. 6.3.1 Beijing Wantai Biology Pharmaceutical Industry Limited Company Information
  15. 6.3.2 Beijing Wantai Biology Pharmaceutical Industry Limited Business Overview
  16. 6.3.3 Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Product Portfolio
  18. 6.3.5 Beijing Wantai Biology Pharmaceutical Industry Limited Recent Developments
7 North America
  1. 7.1 North America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  3. 7.3 North America 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  3. 8.3 Europe 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  3. 10.3 South America 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst